出血ハイリスク患者に対するPCI後の短期DAPT
- 1 January 2020
- journal article
- Published by Japanese Circulation Society in Journal of JCS Cardiologists
- Vol. 29, 15-22
- https://doi.org/10.1253/jjcsc.29.0_15
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trialsThe Lancet, 2017
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting StentsJournal of Invasive Cardiology, 2016
- Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?JACC: Cardiovascular Interventions, 2016
- Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding RiskThe New England Journal of Medicine, 2015
- One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trialCardiovascular Intervention and Therapeutics, 2015
- Guidelines for Elective Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease (JCS 2011) Published in 2012Circulation Journal, 2013
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary StentingJournal of the American College of Cardiology, 2012
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting StentsJournal of the American College of Cardiology, 2012
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingThe New England Journal of Medicine, 1998
- Major Benefit From Antiplatelet Therapy for Patients at High Risk for Adverse Cardiac Events After Coronary Palmaz-Schatz Stent PlacementJournal of the American College of Cardiology, 1997